Effectiveness and safety profile of pembrolizumab for metastatic urothelial cancer: A retrospective single‐center analysis in Japan

BACKGROUND: The paradigm of medical treatment for metastatic urothelial carcinoma is dramatically changing through the introduction of pembrolizumab. AIM: We investigated the treatment effectiveness, the safety profile, and the prognostic factors of pembrolizumab in Japanese real‐world clinical prac...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujiwara, Motohiro, Yuasa, Takeshi, Urasaki, Tetsuya, Komai, Yoshinobu, Fujiwara, Ryo, Numao, Noboru, Yamamoto, Shinya, Yonese, Junji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714548/
https://www.ncbi.nlm.nih.gov/pubmed/33934570
http://dx.doi.org/10.1002/cnr2.1398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714548/
https://www.ncbi.nlm.nih.gov/pubmed/33934570
http://dx.doi.org/10.1002/cnr2.1398

Ejemplares similares